Flavaglines alleviate doxorubicin cardiotoxicity: implication of Hsp27.
<h4>Background</h4>Despite its effectiveness in the treatment of various cancers, the use of doxorubicin is limited by a potentially fatal cardiomyopathy. Prevention of this cardiotoxicity remains a critical issue in clinical oncology. We hypothesized that flavaglines, a family of natura...
Guardado en:
Autores principales: | Yohann Bernard, Nigel Ribeiro, Frédéric Thuaud, Gülen Türkeri, Ronan Dirr, Mounia Boulberdaa, Canan G Nebigil, Laurent Désaubry |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/97ec74df58f24b0f91c10728b83b956b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Flavagline synthetic derivative induces senescence in glioblastoma cancer cells without being toxic to healthy astrocytes
por: Ezeddine Harmouch, et al.
Publicado: (2020) -
Epigallocatechin-3-gallate pretreatment alleviates doxorubicin-induced ferroptosis and cardiotoxicity by upregulating AMPKα2 and activating adaptive autophagy
por: Huan He, et al.
Publicado: (2021) -
Cardioprotective effect of grape polyphenol extract against doxorubicin induced cardiotoxicity
por: Shynggys Sergazy, et al.
Publicado: (2020) -
Resveratrol solid lipid nanoparticles to trigger credible inhibition of doxorubicin cardiotoxicity
por: Zhang L, et al.
Publicado: (2019) -
Cardiomyocyte Stim1 Deficiency Exacerbates Doxorubicin Cardiotoxicity by Magnification of Endoplasmic Reticulum Stress
por: Zhu J, et al.
Publicado: (2021)